Press & News
People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.
The latest news around the IndiTreat® clinical trial in colorectal cancer patients that met its primary endpoint.
February 2, 2021
You can see the full video interview here.